PROK
USDProKidney Corp. Class A Ordinary Shares
$2.800-0.010 (-0.356%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.810
High
$2.825
Low
$2.708
Volume
1.18M
Company Fundamentals
Market Cap
826.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.15M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.46Current $2.800High $7.13
Related News
GlobeNewswire
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
WINSTON-SALEM, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.